Private Wealth Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Private Wealth Management Group’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26	Closed	-$697	–	1436
2025 Q4	$697	Sell	26 -1	-4%	-$26	﹤0.01%	1338
2025 Q3	$720	Sell	27 -152	-85%	-$3.92K	﹤0.01%	1361
2025 Q2	$4.11K	Buy	179 +159	+795%	+$3.95K	﹤0.01%	836
2025 Q1	$580	Buy	+20	New	+$639	﹤0.01%	1374
2024 Q2	–	Sell	-40	Closed	-$1.76K	–	1503
2024 Q1	$1.76K	Hold	40	–	–	﹤0.01%	1030
2023 Q4	$2.47K	Buy	+40	New	+$2.1K	﹤0.01%	889

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Private Wealth Management Group's AMPH Position: Q1 2026 in Review

Private Wealth Management Group sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 26 shares — an estimated $697 sold.

Private Wealth Management Group first reported a position in AMPH in Q4 2023 and held it in 6 quarters. The position peaked at $4.11K in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Private Wealth Management Group reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Private Wealth Management Group sold 26 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $697.
Private Wealth Management Group first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Private Wealth Management Group's Amphastar Pharmaceuticals position peaked at $4.11K in Q2 2025.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.